---
tags: üè° ‚úçÔ∏è üîñ
aliases: 
  - VEGFA
  - VEGF
related:
  - VEGFB
  - VEGFR1
  - VEGFR2
cssclass: idea
publish: true
---
# VEGFA -  vascular endothelial growth factor-A

## Summary
...


## Research
### No reference:
- Is a ligand for both _[[VEGFR1]]_ and _[[VEGFR2]]_.

### Homo Sapiens:
- Endothelial cell survival [^Yancopoulos2000]
- Maintains angiogenesis [^Yancopoulos2000]
- Involved in small airway remodelling [^Wang2017]
- Alveolar destruction in [[COPD]] [^Kawamoto2018]
- Signalling pathways have been assiciated with
  - COPD development [^Boeck2015]
  - COPD phenotypes such as emphysema [^Boeck2015]
- Polymorphisms:
  - risk of lung cancer [^Liu2015][^Maeda2013][^Naykoo2017]
  - changes in lung function [^Simpson2012]
- Expressed in 
  - tissue rich in blood vessels [^Lu2016]
  - inflammatory cells [^Lu2016]
  - lymphatic tissue???
- Nessessary for building lung tissue architecture [^LaddhaKulkarni2019]
- Involved in bronchial microvascular changes [^LaddhaKulkarni2019]
- Involved in the inflammatory response in lung [^LaddhaKulkarni2019]
- Increased expression in COPD exacerbation, not after exacerbation [^Valipour2008]
- Maintenance of
  - endothelial cells [^WestergrenThorsson2018]
  - epithelial cells viability [^WestergrenThorsson2018]
- Lose of _[[VEGFA|VEGF]]_ expression led to
  - endothelial cell apoptosis [^Soltani2016]
  - disapperance of lung tissue [^Soltani2016]

### Animal models:
- Blockage (using sunitinib) of the _[[VEGFA|VEGF]]_ pathway leads to [^Wang2017]
    - less angiogenesis in small airway remodelling
    - slightly disordered lung architecture
    - lower expression of _[[VEGFA|VEGF]]_, _[[VEGFR1]]_, _[[VEGFR2]]_
    - Overall: more severe small airway remodelling in a rat model

### References
[^Boeck2015]: Boeck, L., Mandal, J., Costa, L., Roth, M., Tamm, M., & Stolz, D. (2015). Longitudinal measurement of serum vascular endothelial growth factor in patients with chronic obstructive pulmonary disease. Respiration, 90, 97‚Äì104. https://doi.org/10.1159/000430993
[^Kawamoto2018]: Kawamoto, T., Kanazawa, H., Tochino, Y., & Kawaguchi, T. (2018). Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease. Respiratory Medicine, 141, 159‚Äì 164. https://doi.org/10.1016/j.rmed.2018.07.002
[^LaddhaKulkarni2019]: Laddha, A. P., & Kulkarni, Y. A. (2019). VEGF and FGF-2: Promising targets for the treatment of respiratory disorders. Respiratory Medicine, 156, 33‚Äì 46. https://doi.org/10.1016/j.rmed.2019.08.003
[^Liu2015]: Liu, C., Zhou, X., Gao, F., Qi, Z., Zhang, Z., & Guo, Y. (2015). Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer. Cancer Gene Therapy, 22, 312‚Äì316. https://doi.org/10.1038/cgt.2015.24
[^Lu2016]: Lu, H. Y., Zhao, G. L., & Fu, M. F. (2016). Polymorphisms in the vascular end- othelial growth factor (VEGF) gene associated with asthma. Genetics and Molecular Research, 15. https://doi.org/10.4238/gmr.15027880
[^Maeda2013]: Maeda, A., Nakata, M., Yasuda, K., Yukawa, T., Saisho, S., Okita, R., Hirami, Y., & Shimizu, K. (2013). Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis. Oncology Reports, 29, 39‚Äì44. https://doi.org/10.3892/or. 2012.2075
[^Naykoo2017]: Naykoo, N. A., Dil, A., Rasool, R., Shah, S., Ahangar, A. G., Bhat, I. A., Qasim, I., Siddiqi, M. A., & Shah, Z. A. (2017). Single nucleotide polymorphisms, haplotype association and tumour expression of the vascular endothelial growth factor (VEGF) gene with lung carcinoma. Gene, 608, 95‚Äì102. https://doi.org/10.1016/j.gene.2017.01.007
[^Simpson2012]: Simpson, A., Custovic, A., Tepper, R., Graves, P., Stern, D. A., Jones, M., Hankinson, J., Curtin, J. A., Wu, J., Blekic, M., Bukvic, B. K., Aberle, N., Marinho, S., Belgrave, D., Morgan, W. J., & Martinez, F. D. (2012). Genetic variation in vascular endothelial growth factor-A and lung function. American Journal of Respiratory and Critical Care Medicine, 185, 1197‚Äì 1204. https://doi.org/10.1164/rccm.201112-2191OC
[^Soltani2016]: Soltani, A., Walters, E. H., Reid, D. W., Shukla, S. D., Nowrin, K., Ward, C., Muller, H. K., & Sohal, S. S. (2016). Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 11, 2359‚Äì2367. https://doi.org/10.2147/COPD.S113176
[^Valipour2008]: Valipour, A., Schreder, M., Wolzt, M., Saliba, S., Kapiotis, S., Eickhoff, P., & Burghuber, O. C. (2008). Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease. Clinical Science, 115, 225‚Äì232. https://doi.org/10.1042/CS20070382
[^Wang2017]: Wang, L., Xu, Z., Chen, B., He, W., Hu, J., Zhang, L., Liu, X., & Chen, F. (2017). The role of vascular endothelial growth factor in small-airway remodelling in a rat model of chronic obstructive pulmonary disease. Scientific Reports, 7, 41202. https://doi.org/10.1038/srep41202
[^WestergrenThorsson2018]: Westergren-Thorsson, G., Bagher, M., Andersson-SjoÃàland, A., Thiman, L., LoÃàfdahl, C. G., Hallgren, O., Bjermer, L., & Larsson-Callerfelt, A. K. (2018). VEGF synthesis is induced by prostacyclin and TGF-Œ≤ in distal lung fibroblasts from COPD patients and control subjects: Implications for pulmonary vascular remodelling. Respirology, 23, 68‚Äì75. https://doi.org/ 10.1111/resp.13142
[^Yancopoulos2000]: Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000). Vascular-specific growth factors and blood vessel formation. Nature, 407, 242‚Äì248. https://doi.org/10.1038/35025215
